Literature DB >> 8092265

IL-1 beta stabilizes COX II mRNA in renal mesangial cells: role of 3'-untranslated region.

S K Srivastava1, T Tetsuka, D Daphna-Iken, A R Morrison.   

Abstract

We stimulated rat mesangial cells for different time intervals with interleukin-1 beta (IL-1 beta) and phorbol 12-myristate 13-acetate, prepared cytoplasmic extracts, and examined these extracts for the presence of RNA binding proteins by gel mobility shift assays. Here we report that the 3'-untranslated region (3'-UNTR) of the prostaglandin endoperoxide synthase II (COX II) gene is responsible for posttranscriptional regulation of the response to IL-1 beta. Two cytosolic transacting factors of 65 and 45 kDa, respectively, have been detected that bind to the 3'-UNTR. Competition with excess RNA and acid phosphatase treatment of the cytoplasmic extract suggest the binding is specific and that phosphorylation is required for these rapid binding events. These experiments suggest that IL-1 beta induces the phosphorylation of cytosolic factors, which bind to the 3'-UNTR of COX II mRNA, and stabilizes the message.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092265     DOI: 10.1152/ajprenal.1994.267.3.F504

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Endoplasmic reticulum stress (ER-stress) by 2-deoxy-D-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes.

Authors:  Seon-Mi Yu; Song-Ja Kim
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

2.  Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation.

Authors:  A Ristimäki; K Narko; T Hla
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

Review 3.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

4.  Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells.

Authors:  T Tetsuka; D Daphna-Iken; B W Miller; Z Guan; L D Baier; A R Morrison
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

5.  Impact of FGF1 on human periodontal ligament fibroblast growth, osteogenic differentiation and inflammatory reaction in vitro.

Authors:  Isabel Knaup; Judit Symmank; Asisa Bastian; Sabine Neuss; Thomas Pufe; Collin Jacobs; Michael Wolf
Journal:  J Orofac Orthop       Date:  2021-12-07       Impact factor: 2.341

6.  Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.

Authors:  Anke Doller; El-Sayed Akool; Andrea Huwiler; Roswitha Müller; Heinfried H Radeke; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

7.  A mouse strain less responsive to dioxin-induced prostaglandin E2 synthesis is resistant to the onset of neonatal hydronephrosis.

Authors:  Keiko Aida-Yasuoka; Wataru Yoshioka; Tatsuya Kawaguchi; Seiichiroh Ohsako; Chiharu Tohyama
Journal:  Toxicol Sci       Date:  2014-07-11       Impact factor: 4.849

8.  Imaging cyclooxygenase-2 (Cox-2) gene expression in living animals with a luciferase knock-in reporter gene.

Authors:  Tomo-O Ishikawa; Naveen K Jain; Makoto M Taketo; Harvey R Herschman
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

9.  Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1.

Authors:  T Tetsuka; D Daphna-Iken; S K Srivastava; L D Baier; J DuMaine; A R Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.